Medtech Control Bionics is on track for a record year with YTD unaudited revenue to May 31 up 14% to $5.4 million on the same ...

M&T Bank offers upside with strong loan growth, margins, and dividends, despite macro risks and CRE exposure. Find out why ...

Aviva's Direct Line acquisition boosts EPS by 15%, promising over 10% returns. Read why we continue to find AIVAF stock ...

Brokers gave buy ratings to these ASX shares last week. Why are they bullish? The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.